Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society
Open accessThe DOI matches its Crossref record; 134 of the 141 references it cites were found in a registry or an index; 90 of the 190 sources its claims cite were checked for support.
Abstract
OBJECTIVE: To review the evidence about the impact of hypoglycemia on patients with diabetes that has become available since the past reviews of this subject by the American Diabetes Association and The Endocrine Society and to provide guidance about how this new information should be incorporated into clinical practice. PARTICIPANTS: Five members of the American Diabetes Association and five members of The Endocrine Society with expertise in different aspects of hypoglycemia were invited by the Chair, who is a member of both, to participate in a planning conference call and a 2-day meeting that was also attended by staff from both organizations. Subsequent communications took place via e-mail and phone calls. The writing group consisted of those invitees who participated in the writing of the manuscript. The workgroup meeting was supported by educational grants to the American Diabetes Association from Lilly USA, LLC and Novo Nordisk and sponsorship to the American Diabetes Association from Sanofi. The sponsors had no input into the development of or content of the report. EVIDENCE: The writing group considered data from recent clinical trials and other studies to update the prior workgroup report. Unpublished data were not used. Expert opinion was used to develop some conclusions. CONSENSUS PROCESS: Consensus was achieved by group discussion during conference calls and face-to-face meetings, as well as by iterative revisions of the written document. The document was reviewed and approved by the American Diabetes Association's Professional Practice Committee in October 2012 and approved by the Executive Committee of the Board of Directors in November 2012 and was reviewed and approved by The Endocrine Society's Clinical Affairs Core Committee in October 2012 and by Council in November 2012. CONCLUSIONS: The workgroup reconfirmed the previous definitions of hypoglycemia in diabetes, reviewed the implications of hypoglycemia on both short- and long-term outcomes, considered the implications of hypoglycemia on treatment outcomes, presented strategies to prevent hypoglycemia, and identified knowledge gaps that should be addressed by future research. In addition, tools for patients to report hypoglycemia at each visit and for clinicians to document counseling are provided.
Overview
CoChat Summary
TL;DR
This ADA/Endocrine Society workgroup report updates definitions, risks, and prevention strategies for hypoglycemia in diabetes, with a strong emphasis on avoiding severe episodes and hypoglycemia unawareness. It argues for individualized glycemic targets, better monitoring and education, and further research on outcomes, measurement, and new therapies.
Key findings
- The workgroup defines iatrogenic hypoglycemia as all episodes of abnormally low plasma glucose that expose the person to potential harm, and recommends an alert value of ≤70 mg/dL (≤3.9 mmol/L) for patients at risk; it also classifies episodes as severe, documented symptomatic, asymptomatic, probable symptomatic, or pseudo-hypoglycemia.
- Severe hypoglycemia rates reported in the paper ranged from 115 to 320 per 100 patient-years in type 1 diabetes and 35 to 70 per 100 patient-years in type 2 diabetes; because type 2 diabetes is more common, most hypoglycemia episodes occur in people with type 2 diabetes.
- In ACCORD, intensive glycemic control produced threefold higher hypoglycemia and a 20% increase in mortality; post hoc analyses in ACCORD found severe hypoglycemia had a hazard ratio of 1.41 (95% CI 1.03–1.93) for death.
- In hospitalized patients, one retrospective study found 10.5% of 31,970 general-ward admissions had at least one hypoglycemic episode (≤70 mg/dL), and severe hypoglycemia (≤50 mg/dL) was associated with increased length of stay and greater odds of inpatient death and death within 1 year of discharge.
Methods
- This is a workgroup report/consensus document, not an experimental study; five ADA and five Endocrine Society experts were invited, held a planning call and a 2-day meeting, and developed the manuscript through discussion and iterative revisions.
- The group reviewed recent clinical trials and other studies published since the prior reports; unpublished data were not used, and some conclusions relied on expert opinion.
- Consensus was reached by group discussion and was reviewed/approved by both organizations’ committees in October and November 2012.
Limitations
- The paper states that unpublished data were not used, and that expert opinion was used to develop some conclusions.
- The text makes evident that some evidence is observational, post hoc, or limited by small studies, so causal inference is uncertain in several areas (e.g., mortality, cognition); this is an inference from the paper’s cited evidence, not a limitation explicitly stated in one place.
- The paper explicitly notes gaps in knowledge on hypoglycemia outcomes, mechanisms, and prevention, indicating that several recommendations are based on incomplete evidence.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
59 Valid · 5 Not valid · 33 Not checked · 7 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“There is convincing evidence that formal training programs that teach patients to replace insulin “physiologically” by giving background and mealtime/correction doses of insulin can reduce the risk of severe hypoglycemia.”
§ Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society > What strategies are known to prevent hypoglycemia, and what are the clinical recommendations for those at risk for hypoglycemia? > Patient education
What the sources say
- Supportedcites [100] Mühlhauser, 2002, Patient education—evaluation of a complex intervention, Diabetologia source
The Modelling section describes a structured programme teaching patients to adjust insulin doses, using NPH insulin twice daily and regular insulin before meals. The Long-term implementation section reports decreased rates of severe hypoglycaemia in patients with Type I diabetes and says several prospective studies observed that reduction. The paper supports that such programmes can reduce the risk, although not every evaluation found a reduction. (LLM, conf=0.90)
- Partly supportedcites [101] Bott, 1997, Intensified insulin therapy and the risk of severe hypoglycaemia, Diabetologia sourceExperimental — accuracy not yet measured
The Subjects and methods passage describes structured training in background and mealtime insulin dosing, with patients adjusting doses for glucose and carbohydrate intake. The Results and Discussion report fewer severe hypoglycaemic episodes after the programme, but describe the reduction as an association; they do not establish that training itself caused it. The claim’s description of this as convincing evidence that the programmes can reduce risk is therefore stronger than the paper’s finding. (LLM, conf=0.84)
- Supportedcites [102] Sämann, 2005, Glycaemic control and severe hypoglycaemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: a prospective implementation study, Diabetologia source
The Subjects and methods section describes a structured course teaching background insulin injections and meal-by-meal dose adjustments based on blood glucose and carbohydrate intake. The Abstract reports that severe hypoglycaemia fell from 0.37 to 0.14 events per patient per year after training among people with type 1 diabetes. (LLM, conf=0.92)
- Disputedcites [103] DAFNE Study Group, 2002, Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial, BMJ sourceExperimental — accuracy not yet measured
The skills course section describes training patients to adjust insulin to their meals. But the paper reports that severe hypoglycaemia remained unchanged; the Discussion says there was no significant increase, not a reduction in risk. The claimed risk reduction is therefore contrary to the reported finding. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [104] McIntyre, 2010, Dose adjustment for normal eating (DAFNE)—an audit of outcomes in Australia, Med J Aust source
- Partly supportedcites [105] Hopkins, 2012, Improved biomedical and psychological outcomes 1 year after structured education in flexible insulin therapy for people with type 1 diabetes: the U.K. DAFNE experience, Diabetes Care sourceExperimental — accuracy not yet measured
The Results and Conclusions (pages not provided) report fewer severe hypoglycemia episodes after DAFNE, a structured education program for adults with type 1 diabetes. The paper describes adjusting insulin to carbohydrate intake, but does not specify the claimed background and mealtime/correction-dose teaching. Its evidence is also a retrospective audit based on self-reported hypoglycemia, which qualifies the claim of ‘convincing evidence.’ (LLM, conf=0.82)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“glycemic thresholds for symptoms of hypoglycemia (among other responses) shift to lower plasma glucose concentrations after recent antecedent hypoglycemia (9–12)”
§ Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society > How should hypoglycemia in diabetes be defined and reported?
What the sources say
- Not checked — no full text of the sourcecites [9] Amiel, 1988, Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release, Diabetes source
- Supportedcites [10] Dagogo-Jack, 1993, Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia, J Clin Invest source
The Discussion states that after an episode of hypoglycemia, the authors found elevated glycemic thresholds for neurogenic and neuroglycopenic symptoms, including in patients with IDDM in the present study. Its terminology indicates that an elevated threshold means symptoms occur at a lower plasma glucose concentration. The Results also report reduced symptom responses after antecedent hypoglycemia. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [11] Davis, 1997, Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans, Diabetes source
- Not checked — no full text of the sourcecites [12] Heller, 1991, Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans, Diabetes source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In critical care units, where the accuracy of POC meters is particularly crucial, their performance may be compromised by medications (vasopressors, acetaminophen), treatments (oxygen), and clinical states (hypotension, anemia) (17).”
§ Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society > How should hypoglycemia in diabetes be defined and reported? > The challenge of measuring glucose accurately
What the sources say
- Partly supportedcites [17] Klonoff, 2011, Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline, J Clin Endocrinol Metab sourceExperimental — accuracy not yet measured
Section 1.1 Evidence says supplemental oxygen can cause falsely low readings with glucose-oxidase meters and identifies acetaminophen, pressor use, and hypotension as potential concerns for POC testing in critically ill patients. It also reports an accuracy discrepancy among patients with hypotension or pressor treatment. The cited passages do not address anemia as a cause of compromised meter performance. (LLM, conf=0.88)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“A single threshold value for plasma glucose concentration that defines hypoglycemia in diabetes cannot be assigned because glycemic thresholds for symptoms of hypoglycemia (among other responses) shift to lower plasma glucose concentrations after recent antecedent hypoglycemia (9–12) and to higher plasma glucose concentrations in patients with poorly controlled diabetes and infrequent hypoglycemia”
§ Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society > How should hypoglycemia in diabetes be defined and reported?
What the sources say
- Not checked — no full text of the sourcecites [9] Amiel, 1988, Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release, Diabetes source
- Supportedcites [10] Dagogo-Jack, 1993, Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia, J Clin Invest source
The Discussion (p. 823) reports that antecedent hypoglycemia changes the glycemic threshold for symptoms in patients with insulin-dependent diabetes. The Discussion also reports symptoms at higher plasma glucose concentrations in patients with poorly or moderately controlled diabetes. Together, these findings support the claim that no single symptom-based plasma glucose threshold applies across these circumstances. (LLM, conf=0.91)
- Not checked — no full text of the sourcecites [11] Davis, 1997, Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans, Diabetes source
- Not checked — no full text of the sourcecites [12] Heller, 1991, Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans, Diabetes source
- Not checked — no full text of the sourcecites [13] Boyle, 1988, Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics, N Engl J Med source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Hypoglycemia puts patients at risk for injury and death.”
- Also stated in: § What are the implications of hypoglycemia on both short- and long-term outcomes in people with diabetes? · plain
“There is no doubt that hypoglycemia can be fatal (26).”
§ Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society > How should hypoglycemia in diabetes be defined and reported?
What the sources say
- Supportedcites [26] Cryer, 2011, Death during intensive glycemic therapy of diabetes: mechanisms and implications, Am J Med source
In the main text (page unavailable), Cryer states that iatrogenic hypoglycemia causes recurrent morbidity in people with diabetes and is sometimes fatal. This supports the broad claim that hypoglycemia puts these patients at risk of harm and death. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § What are the implications of hypoglycemia on both short- and long-term outcomes in people with diabetes? · plain
76 more claims · 43 with their cited sources checked
Create a free account to see all 104 claims and to verify the 4 references still open.
- It may state two separate claims as one. 21
- Probably not a substantial claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Postprandial hyperglycemia and resultant compensatory hyperinsulinemia from high dietary glycemic load can lower plasma glucose to concentrations that compromise brain glucose, w70 mg/dL (3.8 mmol/L) (36), triggering the secretion of autonomic counterregulatory hormones such as adrenaline, cortisol, glucagon, and growth hormone (37).”
From High glycemic index diet as a risk factor for depression: analyses from the Women’s Health Initiative (2015) · cites this paper as [36]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Risks for hypoglycemia, particularly level 3 hypoglycemia, include longer duration of diabetes, older age, history of recent level 3 hypoglycemia, alcohol ingestion, exercise, lower education levels, lower household incomes (41), chronic kidney disease, and IAH (103-105).”
From The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (2021) · cites this paper as [103]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recurrent hypoglycaemia results in an increased likelihood of hypoglycaemia unawareness and subsequent severe hypoglycaemic events, since recurrent hypoglycaemia reduces the glucose concentration that triggers the counter-regulatory responses to return to euglycaemia.106”
From Type 1 diabetes (2018) · cites this paper as [106]
The cited source says what the claim attributes to it.
In the citing paper
“Hypoglycemia is a frequent and dangerous complication of diabetes (1), causing changes in physiological parameters (2,3).”
From Noninvasive Hypoglycemia Detection in People With Diabetes Using Smartwatch Data (2023) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“Individualized glucose targets, patient education, nutrition intervention (e.g., bedtime snack to prevent overnight hypoglycemia when specifically needed to treat low blood glucose), physical activity management, medication adjustment, glucose monitoring, and routine clinical surveillance may improve patient outcomes (94).”
From 6. Glycemic Targets: Standards of Care in Diabetes—2023 (2023) · cites this paper as [94]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“Deakin T McShane CE Cade JE Williams RD Group based training for self-management strategies in people with type 2 diabetes mellitus. Cochrane Database Syst Rev 2005; 2: CD003417 15846663”
Cited work 10.1002/14651858.cd003417.pub2 · retracted 2015-06-30 · notice 10.1002/14651858.cd003417.pub3 · this paper published 2013-04-13
Citations
Cites
1 retracted
Group based training for self-management strategies in people with type 2 diabetes mellitus
Deakin, T. A., McShane, C. E., Cade, J. E., & Williams, R. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003417.pub2 · Cited by 862
RetractedIntensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762 · cited 1×
“In VADT, a recent severe hypoglycemic event was the strongest independent predictor of death at 90 days (3).”
BackgroundInzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetologia · doi:10.1007/s00125-012-2534-0 · Cited by 3,919 · cited 2×
“event of troublesome hypoglycemia (96).”
BackgroundIntensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetes Care · doi:10.2337/dc12-0413 · Cited by 3,207
Research works printed but not linked: 2
- Reno, 2011, Deaths due to severe hypoglycemia are exacerbated by diabetes and ameliorated by hypoglycemic pre-conditioning (Abstract), Diabetes, 60, A81
- Aubert, 1995, Diabetes-Related Hospitalization and Hospital Utilization
Cited by
Items 1,001–1,100 of 1,392
Paliwal, S. R., Sulakhiya, K., Kumar, P., Maiti, S., & Paliwal, R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91924-1.00001-0 · Cited by 4
Shah, V. N., Al‐Karadsheh, A., Barnes, C., Mandry, J., Nakhle, S., Wernicke‐Panten, K., Kramer, D., Schmider, W., Pierre, S., Teichert, L., et al. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241232709 · Cited by 4
Kis, J. T., Seufert, J., Haluzík, M., Bonnemaire, M., Vera, C., Tournay, M., Freemantle, N., & Guja, C. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01644-0 · Cited by 4
Søholm, J. C., Nørgaard, S. K., Nørgaard, K., Clausen, T. D., Damm, P., Mathiesen, E. R., & Ringholm, L. (2024) · Diabetic Medicine · doi:10.1111/dme.15467 · Cited by 2
Wang, Y.-C., Chen, Y., Kuo, S., Chen, T.-L., & Chang, F. (2016) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2016.05.011 · Cited by 3
Makrilakis, K., Stathi, C., Vlahodimitris, I., Kalopita, S., Thomakos, P., Konstantopoulos, P. S., Perrea, D. N., Katsilambros, Ν., & Liatis, S. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2017.08.005 · Cited by 5
Aghaali, M., & Saghafi, H. (2018) · Clinical Diabetology · doi:10.5603/dk.2018.0012 · Cited by 4
Ito, H., Tsugami, E., Ando, S., Araki, R., Matsumoto, S., Uemura, K., Nishio, S., Antoku, S., Yamasaki, T., Mori, T., et al. (2018) · Journal of Drug Assessment · doi:10.1080/21556660.2018.1513846 · Cited by 4
“Severe hypoglycemia, defined as an event requiring the assistance of another person to actively administer carbohydrates, glucagon, or take other corrective actions [16], was not noted during the observation period in either the IGlar biosimilar or IGlar U300 group.”
BackgroundCorchuelo, J. C., Guerrero‐Pérez, F., de la Jordana, P. G.-S., & Pérez-Maraver, M. (2019) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2018.06.007 · Cited by 5
Differential diagnosis of hypoglycemia
Schovánek, J., Cibičková, Ľ., Čtvrtlík, F., Fryšák, Z., & Karásek, D. (2020) · Vnitřní lékařství · doi:10.36290/vnl.2020.022 · Cited by 4
“Rozdělení hypoglykemií u diabetiků dle Americké diabetologické společnosti (20)”
Diabetic Emergencies: Ketoacidosis, Hyperglycemic Hyperosmolar State, and Hypoglycemia
Guzman, H., & Lam, D. W.-H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-76097-3.00015-6 · Cited by 3
Halimi, S. (2015) · Diabetes & Metabolism · doi:10.1016/j.diabet.2015.01.005 · Cited by 2
Sugiyama, S., Jinnouchi, H., Hieshima, K., & Jinnouchi, T. (2014) · BMJ Case Reports · doi:10.1136/bcr-2013-201908 · Cited by 3
Braithwaite, D. T., Umpierrez, G. E., & Braithwaite, S. S. (2014) · Journal of Healthcare Engineering · doi:10.1260/2040-2295.5.1.23 · Cited by 3
“The principal risk of insulin treatment is hypoglycemia, generally defined as glucose < 70 mg/dL [11, 12].”
BackgroundHypoglycaemia begets hypoglycaemia
Arora, A. (2013) · BMJ Case Reports · doi:10.1136/bcr-2013-010156 · Cited by 3
Ito, H., Tsugami, E., Ando, S., Imai, A., Matsumoto, S., Omoto, T., Shinozaki, M., Nishio, S., Abe, M., Antoku, S., et al. (2016) · Journal of Clinical Medicine Research · doi:10.14740/jocmr2610w · Cited by 4
“Furthermore, it has been described that a lack of awareness regarding hypoglycemia is frequently observed in patients with type 2 diabetes certain antidiabetic agents [3-5] and that hypoglycemia is associated with cognitive dysfunction [6].”
BackgroundMethodHaemodialysis, nutritional disorders and hypoglycaemia in critical care
Crespo, J. C. L., Gomes, V. R., Barbosa, R. L., Padilha, K. G., & Secoli, S. R. (2017) · British Journal of Nursing · doi:10.12968/bjon.2017.26.5.281 · Cited by 4
Majanović, S. K., Janež, A., Lefterov, I., Tasic, S., & Cikač, T. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0288-x · Cited by 3
“Awareness of these factors are reflected in amendments of international guideline recommendations (ADA/EASD) [12].”
BackgroundOptimal meal time after bolusing for Type 1 diabetes patients under meal uncertainties
Nandi, S., Singh, T., Mastrandrea, L. D., & Singla, P. (2017) · Proceedings of the ... American Control Conference/Proceedings of the American Control Conference · doi:10.23919/acc.2017.7963634 · Cited by 4
Prevention of Falls and Frailty in Older Adults with Diabetes
Hazuda, H. P., & Espinoza, S. E. (2017) · Current Geriatrics Reports · doi:10.1007/s13670-017-0209-x · Cited by 4
Ignaczak, A., Szymańska‐Garbacz, E., Kwiecińska, E., & Czupryniak, L. (2017) · Clinical Diabetology · doi:10.5603/dk.2017.0008 · Cited by 3
Luo, Y., Bao, Y., Zhang, P., Zhu, D., Li, X., Ji, J., Zhang, H., Ji, L., & on behalf of the ORBIT Study Group (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0040 · Cited by 3
Methodology for Developing a Glucose Prediction Model
Georga, E. I., Fotiadis, D. I., & Tigas, S. K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804831-3.00003-0 · Cited by 3
Impact of drugs on hypoglycaemia in hospitalised patients
Vandenberghe, F., Challet, C., Maitrejean, M., Christin, L., & Schaad, N. (2018) · European Journal of Hospital Pharmacy · doi:10.1136/ejhpharm-2017-001375 · Cited by 5
Using Continuous Glucose Monitoring for Patients with Hypoglycemia
Ma, X. J., & Zhou, J. (2018) · Springer eBooks · doi:10.1007/978-981-10-7074-7_13 · Cited by 3
Diabetes in Children and Adolescents
Lora, A. L. M., Paz, M. B., & Klünder‐Klünder, M. (2019) · Springer eBooks · doi:10.1007/978-3-030-11815-0_60 · Cited by 3
Alexopoulos, A., Andersen, A., Donatsky, A. M., Gowda, A., & Buse, J. B. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14397 · Cited by 3
“In DEVOTE, severe hypoglycaemia was defined (as per the American Diabetes Association) as a hypoglycaemic event requiring the assistance of another person for corrective action 18 ; it was an externally adjudicated outcome.”
Nilsen, I., Andersson, A., Laurenius, A., Österberg, J., Sundbom, M., & Haenni, A. (2021) · Nutrients · doi:10.3390/nu13113687 · Cited by 5
“9 mmol/L as cut-off levels for high and low glucose concentrations [24,25].”
BackgroundHamed, M. S., El-Din, A. M. B., & Mostafa, B. M. (2021) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2021.209978 · Cited by 2
Becerra, L. A., Mendez, B., Khan, F. A., Lioutas, V., Novák, P., Mantzoros, C. S., Ngo, L. H., & Novak, V. (2022) · PubMed · Cited by 4
Almalki, M., Aldesokey, H., Alkhafaji, D., Alsheikh, A., Braae, U. C., Lehrskov, L. L., Magawry, W., Yahia, M., & Haroun, A. (2022) · Advances in Therapy · doi:10.1007/s12325-022-02366-0 · Cited by 5
“their answer to the question ‘Howmany of these occurred between midnight and early morning?’ Severe hypoglycaemia was defined as an episode requiring assistance of another person to actively administer carbohydrate, glucagon or take other corrective action [25].”
BackgroundStill, C. D., Benotti, P. N., Hangan, D., & Zubair, F. (2018) · Springer eBooks · doi:10.1007/978-3-319-75841-1_2 · Cited by 6
Vijayakumar, V., Mavathur, R. N., Manjunath, N., & Nagarathna, R. (2019) · International Journal of Yoga · doi:10.4103/ijoy.ijoy_57_18 · Cited by 3
Reducing Hypoglycemia in Type 1 Diabetes: An Incremental Step Forward
Hirsch, I. B. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0174 · Cited by 3
Insulin therapy in diabetic kidney disease
Liu, Y., Zhao, C., Xiong, X., Yang, M., & Sun, L. (2021) · Diabetic Nephropathy · doi:10.2478/dine-2022-0006 · Cited by 2
Chen, M., Zhang, P., Zhao, Y. W., Duolikun, N., & Ji, L. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s386230 · Cited by 2
“categorized as severe hypoglycemia, documented symptomatic, asymptomatic, probable symptomatic or pseudohypoglycemia according to the American Diabetes Association recommendations.(13) Physical examination (body height and weight) and laboratory test (HbA1c and fasting plasma glucose (FPG)) were conducted according to…”
MethodLSTM Networks and Graph Neural Networks for Predicting Events of Hypoglycemia
Hüni, F., Garcia‐Tirado, J., & Riesen, K. (2025) · Lecture notes in computer science · doi:10.1007/978-3-031-80507-3_6 · Cited by 2
Tang, Q., Wang, J., Su, S., Xia, Y., Yu, S., Ren, Q., Meng, Y., & Feng, S. (2025) · Geriatric Nursing · doi:10.1016/j.gerinurse.2025.02.015 · Cited by 4
Mohamed, Y. M., Mancera, J., Brandenberg, A., Fischli, S., & Havranek, M. M. (2025) · PLoS ONE · doi:10.1371/journal.pone.0325956 · Cited by 4
“Hypoglycemia additionally imposes a psychological burden due to its unpredictable nature and the related feelings of fear, affecting quality of life [3,5].”
Christiansen, K., Nørgaard, S. K., Nørgaard, K., Clausen, T. D., Damm, P., Mathiesen, E. R., & Ringholm, L. (2025) · Acta Diabetologica · doi:10.1007/s00592-025-02560-w · Cited by 4
Sakane, N., Kato, K., Hata, S., Nishimura, E., Araki, R., Kouyama, K., Hatao, M., Matoba, Y., Matsushita, Y., Domichi, M., et al. (2025) · Diabetology International · doi:10.1007/s13340-025-00846-6 · Cited by 1
Jayasekera, P. T., Senaratne, T., Lamabadusuriya, D. A., Sathischandra, H., Matthias, A. T., Jayasekera, P., Herath, M., Zoysa, W. D., Senaratne, G., Pathirage, M., et al. (2025) · Journal of Diabetes Research · doi:10.1155/jdr/4412070 · Cited by 2
“Even though plasma glucose concentrations might not be accessible during an incident, the neurological recovery when plasma glucose levels return to normal proves that low plasma glucose induced the event [3].”
Diagnosis and Surgical Management of Pancreatic Insulinoma in a Non-Diabetic Patient: A Case Report
Montenegro, J. F., Penagos, C. E., Rodríguez, D. Y., Ramos, A. F. G., & Liscano, Y. (2025) · Reports — Medical Cases Images and Videos · doi:10.3390/reports8030175 · Cited by 3
“Recognizing rare diseases is crucial because they may be mistaken for more common pathologies or lead to delayed diagnoses [19].”
New paths to attenuate the burden of hypoglycaemia in type 1 diabetes
Monnier, L., & Ds, O. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70512 · Cited by 2
Wang, Y., Jiang, Y., Li, L., Chen, H., Wang, J., Zhang, M., Bai, X., & Wu, S. (2026) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endinu.2025.501759 · Cited by 4
Impact of Inhaled Insulin Therapy on Hypoglycemia
Levy, C. J., & Seaquist, E. R. (2026) · Diabetes Technology & Therapeutics · doi:10.1177/15209156251381294 · Cited by 4
“7,8 In addition to the increased mortality risk associated with severe hypoglycemia, recurrent episodes of hypoglycemia can lead to impaired awareness of hypoglycemia, resulting in a continuous cycle of recurrent hypoglycemia.”
Self-citationComo prevenir y tratar las hipoglucemias farmacológicas
Reyes‐García, R., & Raya, P. M. (2014) · Revista Clínica Española · doi:10.1016/j.rce.2013.12.011 · Cited by 3
Postprandial Hyperinsulinemic Hypoglycemia in Bariatric Surgery
de Heide, L. J. M., Emous, M., & van Beek, A. P. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-804011-9.00054-6 · Cited by 2
Ocena częstości występowania hipoglikemii w zależności od aktywności fizycznej
Zielińska, K., Bysiak-Korus, D., Sosna-Kondera, A., Banaś, E., Bosowska, J., & Strojek, K. (2018) · Clinical Diabetology · doi:10.5603/dk.2018.0005 · Cited by 3
“Two types of hypoglycaemia were differentiated — mild hypoglycaemia, in which the patient was able to self-ingest carbohydrates, and severe hypoglycaemia, when assistance of a third party was necessary [19].”
BackgroundCantero, A. P., Sampalo, A. L., Quirantes, P. L., & Jansen‐Chaparro, S. (2020) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2020.09.022 · Cited by 4
Peralta, F. G., Abreu, C., Benito, M., & Barranco, R. J. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001731 · Cited by 2
Dörfler, H., & Haslbeck, M. (2015) · Springer eBooks · doi:10.1007/978-3-662-43425-3_17 · Cited by 2
Chawla, M. S., Chawla, P., Saboo, B., Chawla, R., Gangopadhyay, K. K., Kalra, S., Aravind, S. R., Sinha, B., Shah, T. U., Kesavadev, J., et al. (2022) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2022.102587 · Cited by 2
Dholariya, S. J., Parchwani, D. N., Dutta, S., & Singh, R. (2022) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2023.2138343 · Cited by 3
“Therefore, any patient who experiences periods of the disturbing level of consciousness, confusion, or seizures during insulin treatment of T1DM should be evaluated for hypoglycemia [7,8].”
BackgroundRecomendaciones para la práctica clínica: hipoglucemia en personas con diabetes mellitus
Martín, C. G., Loredo, S. D., Forlino, M., Rodríguez, A., Ré, M., Santos, N. C. G., Dimov, L., Apoloni, S. B., Remón, J., Ávila, P. J., et al. (2022) · Revista de la Sociedad Argentina de Diabetes · doi:10.47196/diab.v56i2sup.539 · Cited by 6
Oraibi, O., Alameer, A., Dalak, M., Alsharif, S., Hakami, S. A., Sumayli, M. A. A., Shami, A., Mohrag, M., Madkhali, M. A., Madkhali, M. A., et al. (2024) · Current Diabetes Reviews · doi:10.2174/0115733998288242240104054438 · Cited by 3
Ralston, J. D., Anderson, M. L., Ng, J., Bashir, A., Ehrlich, K. J., Burns-Hunt, D., Cotton, M., Hansell, L. D., Hsu, C. W., Hunt, H., et al. (2024) · Contemporary Clinical Trials · doi:10.1016/j.cct.2024.107456 · Cited by 2
Recurrent nocturnal hypoglycemic hemiplegia: a case report and review of the literature
Toyama, H., Takahashi, K., Shimizu, T., Otaka, I., Abe, S., Kato, S., Ando, S., Sato, T., Morii, T., Fujita, H., et al. (2024) · Endocrine Journal · doi:10.1507/endocrj.ej23-0324 · Cited by 2
Clinical Warburg Effect in a Patient With Mantle Cell Lymphoma: A Case Report
Patel, H., Paracha, A., Singhal, A., Wang, K., & Gostanian, N. J. (2024) · Cureus · doi:10.7759/cureus.58768 · Cited by 2
“Ordinarily, when blood glucose drops below 50 mg/dL, neuroglycopenic symptoms begin to emerge, ranging from agitation to death [5,6].”
BackgroundPriorities of self-monitoring of glycemia: an important component of successful diabetes management
Biryukova, E. V., & Викторович, Ш. М. (2024) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2024-202 · Cited by 2
Risk factors for hypoglycaemia in non-critical hospitalised diabetic patients
Garzón, D. V., Forero-Saldarriaga, S., Batancourt, A. M. R., Puerta-Rojas, J. D., Pardo, V. A., Latorre, L. P. F., & Ibáñez‐Pinilla, M. (2024) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2024.02.006 · Cited by 3
Bashir, A., Flatt, A. J., Richell, G., & Shaw, J. (2024) · Diabetic Medicine · doi:10.1111/dme.15389 · Cited by 2
Hannah, K. L., Nemlekar, P. M., Bushman, J. S., & Norman, G. J. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15982 · Cited by 2
Wong, J. Y., Styles, S. E., Wiltshire, E. J., de Bock, M. I., Boucsein, A., Palmer, O. J., & Wheeler, B. J. (2024) · Diabetic Medicine · doi:10.1111/dme.15449 · Cited by 5
MATUS, A. M., Riegel, B. J., & Rickels, M. R. (2024) · Diabetes Care · doi:10.2337/dc24-1720 · Cited by 3
Saidi, A. A., Shamsi, M. A., Farsi, A. A., & Tubi, S. A. (2025) · Cureus · doi:10.7759/cureus.80375 · Cited by 4
Glycemic Variability With Insulin Glargine Versus Detemir in Hospitalized Patients With Diabetes
George, J., Giuliano, C. A., & Hartner, C. L. (2021) · Journal of Pharmacy Practice · doi:10.1177/08971900211017867 · Cited by 2
“Hypoglycemia was classified as mild/moderate (BG 40-69 mg/dL) or severe (BG <40 mg/dL); hyperglycemia was defined as BG >180 mg/dL.(19,20) Other information gathered included creatinine, HbA1c within the last 3 months, diabetes type, and long-acting insulin regimen prior to admission.”
Changes in brain structure and function: under-recognized complications of type 1 diabetes
Nunley, K. A. (2014) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 2
Junctional rhythm during hypoglycaemic encephalopathy
Saleh, A. S. (2015) · Acta Diabetologica · doi:10.1007/s00592-015-0795-z · Cited by 2
Learning About New Therapies: Phase 3 Clinical Studies—And Beyond
Riddle, M. C. (2013) · Diabetes Care · doi:10.2337/dc13-1019 · Cited by 2
“A recent statement by a working group of the American Diabetes Association and The Endocrine Society directly addresses some of these questions, but more work toward improved definitions and methods is needed (17).”
BackgroundThe Unique Needs of the Preschool and Early Elementary School-Age Child With Type 1 Diabetes
Butler, S., Abel, K.-L., & Clark, L. M. (2013) · NASN School Nurse · doi:10.1177/1942602x13495715 · Cited by 3
Diabetes Care to Date: “The Hits Just Keep on Coming!”
Cefalu, W. T. (2013) · Diabetes Care · doi:10.2337/dc13-0906 · Cited by 2
“Specifically, the two statements, one focusing on hypoglycemia and the other on 21st century behavioral medicine, were published within the last 6 months and both were incredibly well received (13,14).”
BackgroundThe Importance of Glycemic Control in the Hospital and the Role of the Infusion Nurse
Klinkner, G. (2016) · Journal of Infusion Nursing · doi:10.1097/nan.0000000000000158 · Cited by 3
Characteristics of Hypoglycemia Pateints Visiting the Emergency Department of a University Hospital
Choi, S.-H., Youn, D.-K., Choi, M. G., & Ryu, O. (2016) · Journal of Korean Diabetes · doi:10.4093/jkd.2016.17.3.202 · Cited by 2
Yousef, M., Westman, A., Lindberg, A., et al. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0110 · Cited by 2
Berković, M. C., Mahečić, D. H., Gradišer, M., & Bilić-Čurčić, I. (2017) · Primary care diabetes · doi:10.1016/j.pcd.2017.02.004 · Cited by 2
Yeo, Q. Q., Chong, J. B. K., Chung, W. L., & Chen, L.-L. (2017) · Journal of Applied Pharmacy · doi:10.21065/1920-4159.1000241 · Cited by 2
“ABC also suffered from CKD coupled with age-related decline in hepatic enzyme activity which may reduce the metabolism of sulfonylureas [7].”
Diabetes, Palliative and End-of-Life Care
Dunning, T. L. (2017) · InTech eBooks · doi:10.5772/67192 · Cited by 3
Nocturnal Hypoglycemia in Type 2 Diabetes
Clus, S., Creţeanu, G., & Popa, A. R. (2018) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.2478/rjdnmd-2018-0011 · Cited by 4
“In terms of cognitive dysfunction, glucose fluctuations contribute at cerebral atrophy and cognitive disorders in patients with T2DM [11].”
BackgroundCHAYKIN, L. B., Bhargava, A., de la Rosa, R., Wysham, C., Troelsen, L. N., Østoft, S. H., & Philis‐Tsimikas, A. (2018) · Clinical Diabetes · doi:10.2337/cd18-0016 · Cited by 5
Yamada, T., Mori, R., Hosoe, J., Shojima, N., Kamata, R., Ishinohachi, K., Yamauchi, T., Tanikawa, Y., & Kadowaki, T. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013164 · Cited by 2
Hypoglycemia: Diagnosis, Management, and Prevention
Faradji, R. N., Uribe-Wiechers, A. C., & Viadero, M. E. S. D. L. M. (2019) · Springer eBooks · doi:10.1007/978-3-030-11815-0_42 · Cited by 2
Reducing the Burden of Diabetes Mellitus in the State of Missouri: A Call to Action.
Drees, B. M., & Yun, S. (2016) · Europe PMC (PubMed Central) · Cited by 2
An Overview of Hypoglycemic Modern Drugs
Chen, H., & Lu, Y. (2021) · Springer eBooks · doi:10.1007/978-981-15-8791-7_2 · Cited by 3
McCarthy, O. M., Pitt, J. P., Eckstein, M. L., Moser, O., Bain, S. C., & Bracken, R. M. (2021) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000002613 · Cited by 2
Fanelli, C. G., Lucidi, P., Bolli, G. B., & Porcellati, F. (2019) · Endocrinology · doi:10.1007/978-3-319-27316-7_22-2 · Cited by 2
Bonhoure, A., Potter, K. J., Reynaud, Q., Boudreau, V., Senior, P. A., Tremblay, F., Lavoie, A., Durieu, I., & RABASA-LHORET, R. P. R. (2021) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2021.11.004 · Cited by 3
Aravind, S. R., Singh, K. P., Mogylnytska, L., Zalevskaya, A. G., Matyjaszek‐Matuszek, B., Wernicke‐Panten, K., Nguyên‐Pascal, M., Pierre, S., Rotthaeuser, B., Kramer, D., et al. (2022) · Diabetes Therapy · doi:10.1007/s13300-022-01279-z · Cited by 2
Recurrent hypoglycemia in a patient with hepatocellular carcinoma
Satar, S. N. A. W., Norhayati, M. N., & Yaacob, L. H. (2023) · Electronic Journal of General Medicine · doi:10.29333/ejgm/12903 · Cited by 2
James, D. E., Shen, T., Geiser, J. S., Garhyan, P., & Chigutsa, E. (2024) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.13153 · Cited by 1
Alabbadi, I. (2015) · Jordan Journal of Pharmaceutical Sciences · Cited by 2
Hyperglycemia in the Intensive Care Unit
Lenhardt, R., & Akça, O. (2015) · Türk yoğun bakım derneği dergisi/Türk yoğun bakım dergisi · doi:10.4274/tybdd.03521 · Cited by 3
“Lately, the definition has been revised to higher levels, marking a plasma glucose of 70 mg/dl hypoglycemia (21,22).”
Impact of hypoglycemic events and HbA1c level on sulfonylurea discontinuation and down-titration
Laires, P. A., Tang, J., Fan, C. P. S., et al. (2016) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2016.1203259 · Cited by 2
“index hypoglycemia was low in this study compared to other observational studies and randomized controlled trials [11,17].”
ResultBarlovič, D. P., Zavratnik, A., Skvarča, A., Janša, K., Vukelic, B. B., Tomažič, M., & Oblak, M. R. (2017) · Slovenian Journal of Public Health · doi:10.1515/sjph-2017-0033 · Cited by 4
“However, data on severe hypoglycaemia incidence is much more reliable (13).”
BackgroundResultNg, D., Noor, N. M., & Yong, S. L. (2019) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.034.01.06 · Cited by 2
Sharma, D., Gerlach, M., Sharma, V., & Dhatariya, K. (2019) · British Journal of Diabetes · doi:10.15277/bjd.2019.210 · Cited by 3
Differential Flatness based Run-to-Run Control of Blood Glucose for People with Type 1 Diabetes
Nandi, S., & Singh, T. (2019) · Proceedings of the ... American Control Conference/Proceedings of the American Control Conference · doi:10.23919/acc.2019.8815360 · Cited by 4
Fadini, G. P., Giordano, C. S. D. S., Salvi, L., Nicolucci, A., & The REFLECT Italian Study Group (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00936-5 · Cited by 2
Seino, Y., Miyoshi, H., Bosch‐Traberg, H., Divyalasya, T. V. S., Nishijima, K., & Terauchi, Y. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13789 · Cited by 2
Muriel, R. A. S. (2022) · Gredos (University of Salamanca) · doi:10.14201/gredos.149564 · Cited by 2
Metadata
- Authors
- Seaquist, E. R., Anderson, J., Childs, B., Cryer, P., Dagogo-Jack, S., Fish, L., Heller, S. R., Rodriguez, H., Rosenzweig, J., & Vigersky, R.
- Affiliations
- University of Minnesota (US)
- The Frist Clinic, Nashville, Tennessee;
- Mid-America Diabetes Associates, Wichita, Kansas; the
- Washington University in St. Louis (US)
- University of Tennessee Health Science Center (US)
- Park Nicollet Clinic (US)
- University of Sheffield (GB)
- University of South Florida (US)
- Boston University (US)
- Walter Reed National Military Medical Center (US)
- Corresponding author
- Seaquist, Elizabeth R.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2013-04-13
- Volume
- 36
- Issue
- 5
- Pages
- 1384-1395
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3631867
- OpenAlex
- W2109416725
- Cited by
- 1,389
- References
- 141
- Citations by year
- 2026: 43 · 2025: 47 · 2024: 62 · 2023: 66 · 2022: 92 · 2021: 127 · 2020: 119 · 2019: 149 · 2018: 148 · 2017: 151 · 2016: 129 · 2015: 129 · 2014: 92 · 2013: 33
- FWCI
- 100.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- Eli Lilly and Company
- Sanofi
- National Institute for Health and Care Research (NF-SI-0611-10248)
- Novo Nordisk
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Patient Safety and Medication Errors
- Keywords
- hypoglycemia, diabetes mellitus, hypoglycemia definition, hypoglycemia prevention, long-term outcomes, patient counseling, clinical guidelines
- MeSH terms
- Diabetes Mellitus, Humans, Hypoglycemia, Societies, Medical, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.